Header Logo

Connection

David Moore to Anti-Retroviral Agents

This is a "connection" page, showing publications David Moore has written about Anti-Retroviral Agents.
Connection Strength

2,807
  1. The Etiology of Pneumonia in HIV-1-infected South African Children in the Era of Antiretroviral Treatment: Findings From the Pneumonia Etiology Research for Child Health (PERCH) Study. Pediatr Infect Dis J. 2021 Sep 01; 40(9S):S69-S78.
    View in: PubMed
    Score: 0,553
  2. At-Risk Alcohol Use is Associated with Antiretroviral Treatment Nonadherence Among Adults Living with HIV/AIDS. Alcohol Clin Exp Res. 2017 Aug; 41(8):1518-1525.
    View in: PubMed
    Score: 0,415
  3. Antiretroviral therapy reduces neurodegeneration in HIV infection. AIDS. 2015 Jan 28; 29(3):323-30.
    View in: PubMed
    Score: 0,350
  4. HIV-infected individuals with co-occurring bipolar disorder evidence poor antiretroviral and psychiatric medication adherence. AIDS Behav. 2012 Nov; 16(8):2257-66.
    View in: PubMed
    Score: 0,300
  5. Prevalence, incidence and mortality associated with tuberculosis in HIV-infected patients initiating antiretroviral therapy in rural Uganda. AIDS. 2007 Mar 30; 21(6):713-9.
    View in: PubMed
    Score: 0,204
  6. Perceived risks and amelioration of harm in research using mobile technology to support antiretroviral therapy adherence in the context of methamphetamine use: a focus group study among minorities living with HIV. Harm Reduct J. 2020 06 11; 17(1):41.
    View in: PubMed
    Score: 0,127
  7. Tailoring a mobile health text-messaging intervention to promote antiretroviral therapy adherence among African Americans: A qualitative study. PLoS One. 2020; 15(6):e0233217.
    View in: PubMed
    Score: 0,127
  8. Association of antiretroviral therapy with brain aging changes among HIV-infected adults. AIDS. 2018 09 10; 32(14):2005-2015.
    View in: PubMed
    Score: 0,113
  9. Coagulation imbalance and neurocognitive functioning in older HIV-positive adults on suppressive antiretroviral therapy. AIDS. 2017 03 27; 31(6):787-795.
    View in: PubMed
    Score: 0,102
  10. Elevated Markers of Vascular Remodeling and Arterial Stiffness Are Associated With Neurocognitive Function in Older HIV+ Adults on Suppressive Antiretroviral Therapy. J Acquir Immune Defic Syndr. 2017 Feb 01; 74(2):134-141.
    View in: PubMed
    Score: 0,101
  11. Impact of the antiretroviral treatment program on the burden of hospitalization for culture-confirmed tuberculosis in South African children: a time-series analysis. Pediatr Infect Dis J. 2013 Sep; 32(9):972-7.
    View in: PubMed
    Score: 0,079
  12. Identification of an abbreviated test battery for detection of HIV-associated neurocognitive impairment in an early-managed HIV-infected cohort. PLoS One. 2012; 7(11):e47310.
    View in: PubMed
    Score: 0,075
  13. CD4 cell count and viral load monitoring in patients undergoing antiretroviral therapy in Uganda: cost effectiveness study. BMJ. 2011 Nov 09; 343:d6884.
    View in: PubMed
    Score: 0,070
  14. Sexual behavior and HIV transmission risk of Ugandan adults taking antiretroviral therapy: 3 year follow-up. AIDS. 2011 Jun 19; 25(10):1317-27.
    View in: PubMed
    Score: 0,068
  15. A CD4+ cell count <200 cells per cubic millimeter at 2 years after initiation of combination antiretroviral therapy is associated with increased mortality in HIV-infected individuals with viral suppression. J Acquir Immune Defic Syndr. 2010 Dec; 55(4):451-9.
    View in: PubMed
    Score: 0,066
  16. Two-year follow-up of sexual behavior among HIV-uninfected household members of adults taking antiretroviral therapy in Uganda: no evidence of disinhibition. AIDS Behav. 2010 Aug; 14(4):816-23.
    View in: PubMed
    Score: 0,057
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.